Royal London Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$183M	Buy	3,808,353 +3,628,670	+2,019%	+$159M	0.38%	48
2025 Q4	$6.94M	Buy	179,683 +1,212	+0.7%	+$46.2K	0.01%	500
2025 Q3	$6.3M	Hold	178,471	–	–	0.01%	517
2025 Q2	$6.43M	Sell	178,471 -3,073	-2%	-$102K	0.01%	520
2025 Q1	$5.65M	Buy	181,544 +3,849	+2%	+$122K	0.01%	550
2024 Q4	$4.53M	Buy	177,695 +17,511	+11%	+$464K	0.01%	561
2024 Q3	$4.53M	Buy	160,184 +4,307	+3%	+$119K	0.01%	563
2024 Q2	$4.11M	Sell	155,877 -183,688	-54%	-$5.09M	0.01%	568
2024 Q1	$10.3M	Buy	339,565 +17,769	+6%	+$524K	0.03%	395
2023 Q4	$9.04M	Buy	321,796 +3,282	+1%	+$90.2K	0.03%	401
2023 Q3	$8.65M	Buy	318,514 +52,524	+20%	+$1.56M	0.03%	399
2023 Q2	$8.17M	Buy	265,990 +123,566	+87%	+$4.19M	0.03%	401
2023 Q1	$5.13M	Buy	142,424 +14,803	+12%	+$549K	0.02%	468
2022 Q4	$5.04M	Buy	127,621 +7,612	+6%	+$318K	0.02%	451
2022 Q3	$4.82M	Sell	120,009 -3,979	-3%	-$170K	0.02%	438
2022 Q2	$5.22M	Hold	123,988	–	–	0.02%	437
2022 Q1	$4.83M	Buy	123,988 +5,904	+5%	+$232K	0.02%	511
2021 Q4	$4.71M	Hold	118,084	–	–	0.02%	508
2021 Q3	$4.27M	Hold	118,084	–	–	0.02%	535
2021 Q2	$4.84M	Hold	118,084	–	–	0.02%	523
2021 Q1	$5.15M	Buy	+118,084	New	+$5.6M	0.02%	486